Pfizer (NY: PFE )
40.81 +0.71 (+1.77%) Official Closing Price Updated: 6:30 PM EDT, Mar 20, 2023 Add to My Watchlist
Press Releases about Pfizer
Pfizer Invests $43 Billion to Battle Cancer
March 13, 2023
From Seagen Inc.
Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its
Topics Initial Public Offering
Exposures COVID-19 Product Safety Securities Market
Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance
February 22, 2023
Salivary Gland Cancer Treatment Market Outlook Growth Share Overview Analysis 2022-2029
February 17, 2023
Global Salivary Gland Cancer Treatment Market to Witness Huge Growth by Key Players: Bristol-Myers Squibb Company, LGM PHARMA, Pfizer Inc., Bedford Laboratories, Baxter, sanofi-aventis U.S. LLC, Pierre...
Global Choroidal Neovascularization Market to Witness Huge Growth by Key Players: Bausch Health Companies Inc, Bayer AG, Gilead Sciences Inc, F.Hoffmann –La Roche AG,MaaT Pharma Novartis AG, Pfizer...
Undifferentiated Pleomorphic Sarcoma Therapeutics Market Share Volume Demand 2022 to 2029
February 14, 2023
The Undifferentiated Pleomorphic Sarcoma Therapeutics Market size was valued USD million in 2021 and is estimated to reach USD million by 2029, growing at a high CAGR during the forecast period...
FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)
February 10, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following